Yekaterina Chudnovsky - Jun 28, 2024 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role
Director, 10%+ Owner
Signature
/s/ Yekaterina Chudnovsky
Stock symbol
ELTX
Transactions as of
Jun 28, 2024
Transactions value $
$7,984,000
Form type
4
Date filed
7/2/2024, 04:30 PM
Previous filing
Jun 21, 2024
Next filing
Aug 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Common Warrants Purchase $0 +1.6M $0.00 1.6M Jun 28, 2024 Common Stock 1.6M $5.00 Direct F1, F2
transaction ELTX Pre-Funded Warrants Purchase $7.98M +1.6M $4.99 1.6M Jun 28, 2024 Common Stock 1.6M $0.01 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%.
F2 The Common Warrants expire on July 1, 2029.
F3 Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%.
F4 The Pre-Funded Warrants do not have an expiration date.